Stock gainers & losers on January 13, 2025

Demand for Moderna's Covid-19 vaccines sinks & J&J's biggest acquisition in more than 2 years

In partnership with

Daily Stock Spotlight


Good evening. Nvidia's stock dropped about 2% after the U.S. government introduced new rules to limit AI exports to “adversaries” like China.

Investors are on edge this week, awaiting the wholesale inflation report tomorrow and the Consumer Price Index (CPI), a key inflation measure, on Wednesday.

⬆ 34.07% Intra-Cellular Therapies (NASDAQ: ITCI)

Johnson & Johnson buys the neurological drug maker Intra-Cellular Therapies at a 39% premium for $14.6 billion, its biggest deal in more than two years, boosting its presence in the market for brain disease treatments.

⬆ 30.72% Trump Media (NASDAQ: DJTWW)

The parent company of the right leaning social media Truth Social surged following news that the company was in “advanced talks” to buy cryptocurrency trading firm Bakkt.

It's Time To Rethink Your Media Diet

Financial news is full of clickbait and fear tactics, wasting your time and clouding your judgment. The Daily Upside delivers expert insights—free every morning. Join 1M+ readers today!

⬇ 15.66% Abercrombie & Fitch (NYSE: ANF)

The rejuvenated clothing brand told investors to expect fourth-quarter net sales growth of 7% to 8%, up from an earlier estimate of 5% to 7%. Investors were hoping for an even more optimistic number.

⬇ 16.80% Moderna (NASDAQ: MRNA)

The biotech company sinks after yet another disappointing financial update with investors worried that the company is going to run out of money, as the demand for Covid-19 vaccines has collapsed.

 1-day change
Market data: today’s market close